Global Pharmaceutical Gelatin Market – Industry Trends and Forecast to 2030

Pharmaceutical Gelatin Market Analysis and Size

The increasing application of gelatin in cosmetic applications, intrinsic activities, and biomedical applications in wound dressing and wound healing, tissue engineering, gene therapy, implants, and bone substitutes is boosting the market growth. Increasing demand for gelatin in functional food applications because of its ability to prevent several diseases, improve food quality, and protect food is projected to fuel market growth.

Data Bridge Market Research analyses a growth rate in the pharmaceutical gelatin market in the forecast period 2023-2030. The expected CAGR of pharmaceutical gelatin market is tend to be around 5.7% in the mentioned forecast period. The market was valued at USD 1.26 billion in 2022, and it would grow upto USD 1.97 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pharmaceutical Gelatin Market Scope and Segmentation

Market Definition

Gelatin is a raw material that is used in the pharmaceutical industry. Gelatin capsules protects ingredients such as fish oil from oxygen, light, contamination or microbial growth. It is an essential factor that is used for the production of hard and soft capsules as well as film-coated and effervescence tablets. Around, 90% of all the pharmaceutical gelatin produced is processed into widely used drug dosage form.

Pharmaceutical Gelatin Market Dynamics

Drivers

• Increasing Demand of Choosing Healthy Lifestyle

The in-home consumption of convenience meals increased to 26% during the pandemic. Understanding the importance of health as a lifestyle choice has stimulated consumers in the F&B sector. Though, in the above forecast period, the personal care category is the market's fastest-growing segment, with a CAGR of 5.51%, by value because of higher average protein content of 5% in pharmaceutical gelatin compared to other dairy proteins like whey & milk proteins.

• Preference of Collagen Consumption

Most consumers prefer collagen consumption through their diet instead of taking it through injections, that is likely to produce higher product penetration in the food and beverage industry. For instance, numerous manufacturers, namely JBS and JIANGXI COSEN BIOLOGY CO., LTD. produce bovine grade collagen for food and beverage applications. Increasing demand for the mentioned products in confectionery and desserts is expected to boost the market growth.

Opportunities

• Increasing Technological Development

The increase in initiatives from the major market players to manufacture innovative gelatin capsules shells with innovative technologies is creating much opportunities for the market bgrowth. For instance, etectRx, Inc., which is a digital health startup, launched the beginning of a study to track antiretroviral therapy adherence among prescription opioid users who are surviving with human immuno virus (HIV). The "MyTPill" trial will assess patient adherence using the ID-Cap System which involves a hard gelatin capsule with an embedded ingestible wireless sensor and a wearable reader. Such great initiatives will lead to increased adoption of gelatin for the production of hard gelatin capsules (ID-Cap) boosting the market growth.

• Increase in Launch of New Products

The increase in the launch of new gelatin brands is also projected to drive the market growth in this region. For instance, in May 2021, GelDAT was launched by Darling Ingredients' Rousselot Brand. It launched X-Pure - GelDAT as an alternative for GelTYR - Gelatin Tyramine by considering the limitations, irreproducibility, and lack of a scalable production process of GelTYR. Such launch of innovative products will further boost the market growth because of the rise in adoption to their improved properties. Thus, all these factors are creating much opportunities for the market growth.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified healthcare professionals who are unable to use these devices could limit the growth of the global pharmaceutical gelatin market over a forecast period.

• High Cost of Gelatins

The huge expenditure that is associated with the gelatins are majorly impacting the growth of the market.  Prices have increased recently as there is huge concern that the higher feed prices seen because of the recent drought in Russia and the U.S. may be leading to a decline in the number of the animals from which gelatin is produced.

This pharmaceutical gelatin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical gelatin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Pharmaceutical Gelatin Market

COVID-19 has a great impact on the gelatin production and the supply chain. Lonza, which is a key player in the capsules segment, has stated that COVID-19 has impacted the demand and supply chain of pharmaceutical capsules. Whereas, gelatin also has found its importance in the COVID-19 treatment. For instance, as per the study titled 'Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19' in May 2022, the addition of gelatin to the drug delivery considerably stabilizes the proteins and enhances the fractions of active proteins after nebulization, diminishing the medication dosage. Such many advantages of gelatin in COVID-19 patient's treatment will lead to higher adoption of pharmaceutical gelatin

Recent Developments

• In 2022, Lonza expanded its Capsugel offering with a titanium dioxide-free (TiO2-free) white hard gelatin capsule, meeting the demand of the food industry to meet requirements for foods in the European Union.

Global Pharmaceutical Gelatin Market Scope

The pharmaceutical gelatin market is segmented on the basis of type, treatment, source, route of administration, end-users, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Porcine
• Bovine Skin
• Bovine Bone
• Fish
• Poultry  

Function

• Stabilizing
•  Thickening
• Gelling  

End-Users

• Hard Capsule
• Soft Capsule
• Tablet
• Absorbable Hemostat

Pharmaceutical Gelatin Market Regional Analysis/Insights

The pharmaceutical gelatin market is analyzed and market size insights and trends are provided by type, treatment, source, route of administration, end-users, distribution channel as referenced above.

The major countries covered in the pharmaceutical gelatin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pharmaceutical gelatin market because of the presence of several key manufacturers of gelatin produced in pharmaceutical industry in terms of volume.

Asia-Pacific is considered to have the most lucrative growth because of the lower labour and capital costs for the manufacturing of pharmaceutical gelatin and increased frequency of osteoarthritis and obesity disorders globally.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Pharmaceutical Gelatin Market Share Analysis

The pharmaceutical gelatin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to pharmaceutical gelatin market

Key players operating in the pharmaceutical gelatin market include:

• Gelita AG (Germany)
• Trobas Pharmaceutical gelatine B.V (Netherlands)
• Rousselot (U.S.)
• Weishardt (France)
• Sterling Gelatin (India)
• Catalent, Inc (U.S.)
• Nitta Pharmaceutical gelatin India Limited (India)
• Aspire Pharmaceuticals (U.S.)
• Junca Gelatines (Spain)
• Gelco International (Brazil)
• Norland Products Inc (U.S.)
• Lapi Gelatine S.p.a (Italy)
• Trobus Gelatine B.V. (Netherlands)

SKU-58567